Low estrogen can result from natural aging, medical conditions, lifestyle factors, or treatments that damage or disrupt the ovaries and the hormonal signaling chain that controls them. For premenopausal women, normal estradiol (the primary form of estrogen) ranges from 10 to 300 pg/mL. Postmenopausal levels typically fall below 10 pg/mL. Understanding what drives estrogen down helps explain symptoms like hot flashes, irregular periods, vaginal dryness, and bone loss.
How Your Body Makes Estrogen
Estrogen production depends on a chain of signals between three structures: the hypothalamus in your brain, the pituitary gland just below it, and the ovaries. The hypothalamus releases a hormone called GnRH in regular pulses, which tells the pituitary to produce two messenger hormones, FSH and LH. FSH then stimulates cells in the ovaries to convert androgens into estradiol using a specific enzyme called aromatase. A problem at any point in this chain can reduce estrogen output.
This system also runs on feedback loops. When estrogen and progesterone levels rise, they signal the hypothalamus to slow down GnRH pulses, which in turn reduces FSH and LH. That’s normal cycling. But when something externally suppresses GnRH, or when the ovaries can’t respond to FSH, estrogen drops and stays low.
Perimenopause and Menopause
The most common cause of declining estrogen is the natural transition toward menopause. Perimenopause typically begins in the mid-40s but can start as early as the mid-30s or as late as the mid-50s. It lasts roughly eight to ten years before menopause itself. During this window, estrogen doesn’t decline in a smooth line. Levels fluctuate unpredictably, sometimes spiking higher than normal before crashing, which is why symptoms like hot flashes and mood changes can feel so erratic.
Once you reach menopause (defined as 12 consecutive months without a period), your ovaries produce so little estrogen that ovulation stops permanently. Postmenopausal estradiol levels fall below 10 pg/mL, a fraction of the premenopausal range. This sustained low level is what drives longer-term consequences like accelerated bone loss and changes to vaginal and urinary tissue.
Primary Ovarian Insufficiency
When ovarian function declines before age 40, it’s called primary ovarian insufficiency (POI), sometimes referred to as premature ovarian failure. Women with POI develop irregular periods and reduced fertility years earlier than expected. The ovaries either run out of functioning follicles prematurely or stop responding to FSH. Because the ovaries aren’t producing enough estrogen, the pituitary ramps up FSH production in an attempt to compensate, so blood tests typically show elevated FSH alongside low estradiol.
POI affects roughly 1 in 100 women under 40. Causes include autoimmune conditions (where the immune system attacks ovarian tissue), genetic factors, and sometimes prior surgery or medical treatment. In many cases, no specific cause is identified.
Genetic and Chromosomal Conditions
Turner syndrome is one of the clearest genetic causes of low estrogen. It occurs in people born with one X chromosome instead of two, leading to ovaries that don’t develop properly. Without functional ovarian tissue, the body can’t produce adequate estrogen on its own. Blood tests show the same pattern as POI: very high FSH and LH (because the pituitary keeps trying to stimulate ovaries that can’t respond) alongside very low estradiol. Most people with Turner syndrome need estrogen replacement starting in adolescence to support puberty, bone health, and cardiovascular function.
Cancer Treatments
Chemotherapy and radiation therapy can damage the ovaries directly, sometimes permanently. Among traditional chemotherapy drugs, alkylating agents pose the highest risk because they are toxic to the primordial follicles, the reserve of immature eggs the ovaries draw from throughout reproductive life. Platinum-based drugs also carry risk for egg damage. Taxanes are associated with moderate risk, while drugs like methotrexate and vincristine tend to be lower risk.
Age plays a major role in whether ovarian damage is reversible. In a large study of over 1,600 women, 83% lost their periods in the first year after chemotherapy. By year four, that number dropped to about 67% overall as some women’s ovaries recovered. But the picture varied dramatically by age: women 45 and older had roughly a 90% chance of permanent menstrual loss across all four years of follow-up, while the risk for women 44 and younger ranged from 23% to 73% depending on their specific age. Younger ovaries, with a larger follicle reserve, are more resilient.
Pituitary and Hypothalamic Problems
Because estrogen production depends on signals from the brain, damage to the pituitary gland can shut down the entire chain. Sheehan syndrome is a classic example. It occurs when severe blood loss during childbirth damages the pituitary, reducing its ability to produce FSH and LH. Without those messenger hormones, the ovaries receive no signal to make estrogen. The result is low estrogen alongside low FSH and LH, a pattern that distinguishes pituitary problems from ovarian ones (where FSH is typically high).
Pituitary tumors, head injuries, and radiation to the brain can cause similar disruptions. High prolactin levels, a condition called hyperprolactinemia, also suppress estrogen by blocking GnRH release from the hypothalamus. Prolactin-producing pituitary tumors are one of the more common causes, but certain medications (particularly some psychiatric drugs) can raise prolactin as well.
Thyroid Disorders
Hypothyroidism, or an underactive thyroid, can lower estrogen through an indirect route. When thyroid hormone is low, the brain increases production of TRH (thyrotropin-releasing hormone) to try to stimulate the thyroid. But elevated TRH also raises prolactin levels, and high prolactin suppresses GnRH, the hormone that kicks off the entire estrogen production chain. This means untreated hypothyroidism can lead to irregular or absent periods and low estrogen, symptoms that often resolve once thyroid function is corrected.
Stress and Its Hormonal Effects
Chronic physical or emotional stress suppresses estrogen through a well-documented mechanism. Stress triggers the release of beta-endorphin, an opioid peptide that directly inhibits GnRH-secreting neurons in the hypothalamus. With less GnRH, the pituitary produces less FSH and LH, and the ovaries receive weaker signals to produce estrogen. This is the same pathway that causes missed periods in people under extreme physical or psychological strain.
The most recognized version of this is hypothalamic amenorrhea, where periods stop entirely due to stress, excessive exercise, caloric restriction, or some combination of the three. It’s particularly common in competitive athletes and people with eating disorders. The University of Rochester Medical Center specifically lists rapid weight loss and anorexia as causes of low estradiol in premenopausal women.
Smoking
Women who smoke have measurably lower estrogen levels than nonsmokers, along with higher concentrations of estrogen breakdown products in their urine. Tobacco smoke drives this in two ways. First, the polyaromatic hydrocarbons in smoke activate liver enzymes (in the CYP family) that break down estrogen faster than normal. Essentially, the liver clears estrogen from the bloodstream more aggressively. Second, nicotine itself inhibits aromatase, the enzyme the ovaries use to convert androgens into estrogen, reducing production at the source.
This dual effect helps explain why women who smoke tend to reach menopause one to two years earlier than nonsmokers and are more likely to experience hot flashes. Nicotine also stimulates dopamine release, which can further suppress GnRH signaling.
Extreme Exercise and Low Body Weight
Body fat plays an active role in estrogen production. Fat tissue contains aromatase and converts small amounts of androgens into estrogen, supplementing what the ovaries make. When body fat drops very low, this source diminishes. Combine that with the stress-related suppression of GnRH that comes from intense training or caloric deficit, and estrogen levels can fall dramatically.
This is why amenorrhea is so common among endurance athletes, ballet dancers, and others whose training demands consistently outpace their caloric intake. The condition is reversible with adequate nutrition and reduced training intensity, though recovery of normal cycles can take months.
Surgical Removal of the Ovaries
Bilateral oophorectomy, the surgical removal of both ovaries, causes an immediate and permanent drop in estrogen. Unlike natural menopause, where levels decline gradually over years, surgical menopause happens overnight. This abrupt loss tends to produce more intense symptoms, including severe hot flashes, sleep disruption, and rapid bone density loss. Women who have their ovaries removed before natural menopause age face a longer period of estrogen deficiency, which is why hormone replacement is often considered in these cases.
Even removal of one ovary can modestly reduce estrogen output, though the remaining ovary usually compensates over time. Hysterectomy without ovary removal does not directly lower estrogen, though it may affect blood flow to the ovaries and slightly accelerate the timeline to menopause in some women.